CUSIP 37148K209COM NEWQ4 2025
9 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Atlas Venture Life Science Advisors, LLC | 827.9K | $4.70M |
| 2 | Symbiosis Capital Partners, LLC | 665.0K | $3.78M |
| 3 | Opaleye Management Inc. | 310.0K | $1.76M |
| 4 | Renaissance Technologies LLC | 287.6K | $1.63M |
| 5 | Vanguard Group Inc | 229.8K | $1.31M |
| 6 | Siren, L.L.C. | 201.4K | $1.14M |
| 7 | Ubs Group AG | 164.7K | $935.6K |
| 8 | Morgan Stanley | 161.4K | $916.6K |
| 9 |
| 4 | Feb 6, 2026 | Baselake Partners, LP | 13G | 5.2% | 350.0K | SEC |
| 5 | Nov 14, 2025 | Symbiosis Capital Partners, LLC | 13G/A | 6.3% | 421.9K | SEC |
| 6 | Nov 14, 2025 | Symbiosis Capital Partners, LLC | 13G | 6.3% | 421.9K | SEC |
| 7 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 8.6% | 576.8K | SEC |
| 8 | Nov 13, 2025 | Renaissance Technologies LLC | 13G | 5.1% | 344.3K | SEC |
| 9 | Aug 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 12.6% | 8.46M | SEC |
| Marshall Wace, LLP |
| 140.3K |
| $796.9K |
| 10 | Yiheng Capital Management, L.P. | 105.5K | $599.4K |